Credits Available: 5.00 AMA PRA Category 1 Credit™, ABIM MOC

Description: The Type 2 inflammatory response plays a key role in several conditions, including atopic dermatitis, eosinophilic esophagitis, and asthma. While these diseases may present differently, they share a common underlying pathway, creating opportunities for more targeted and effective treatments. Pediatricians are well versed in managing these conditions, and recognizing their interconnections can help optimize patient care.

Exciting advancements in treatment, including biologics and other innovative therapies, offer new hope for patients with more severe forms of Type 2 inflammatory diseases. While these treatments are typically initiated by subspecialists, pediatricians play a vital role in identifying patients who may benefit from these options and guiding them through the referral process.

This program will provide valuable insights into recognizing comorbidities, making informed treatment decisions, and ensuring timely referrals so that patients receive therapies that address the root cause of their disease, not just the symptoms.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Pediatrics

Allison Burbank

University of North Carolina Chapel Hill
Associate Professor of Pediatrics

I am a pediatric allergy and immunology specialist, and my primary clinical and research interests include severe pediatric asthma and food allergy. My research has focused on environmental influences on asthma, novel anti-inflammatory treatments for asthma, and digital technology interventions to improve asthma management in children and adolescents.